SOURCE: Solos Endoscopy, Inc.

May 23, 2007 08:31 ET

Solos Breast Endoscopy System Receives Praise From Physician at Renowned Breast Cancer Research Foundation

BOSTON, MA -- (MARKET WIRE) -- May 23, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to announce that the Company has received positive feedback from several of the doctors who have been evaluating the Solos Breast Endoscopy system. The system is ideal for performing ductoscopy procedures, which allows physicians to examine the mammary ducts under direct visualization. This direct visualization allows earlier detection than other procedures, including mammography.

"We have been very pleased with the images provided by the Solos Breast Endoscopy system. This technology has the potential to help us understand what causes breast cancer and that would allow us to develop better treatments," stated Dr. Dixie Mills of the Dr. Susan Love Research Foundation.

The mission of the Dr. Susan Love Research Foundation is to eradicate breast cancer and improve the quality of women's health through innovative research, education and advocacy. Over the last decade, 2,000 breast cancer organizations have raised over $2 billion dollars for breast cancer research. The Dr. Susan Love Research Foundation believes that to eradicate breast cancer, doctors need to begin where breast cancer begins -- in the breast ducts.

"Over the last several months, we have been sending out our Solos Breast Endoscopy system for evaluations at various hospitals and clinics throughout the country. The positive responses that we have received from national doctors have reaffirmed our belief that our technology can play a major role in the early detection of breast cancer," stated Dee Fletcher, Vice President of Sales.

Solos Endoscopy, Inc. recently announced that the Company has signed a distribution agreement with General Commerce and Trade S.A. de C.V. of Monterey, Mexico. General Commerce and Trade is in the process of registering the Solos Breast Endoscopy System for general sale in Mexico and is assisting the Company with negotiations to introduce the Solos Breast Endoscopy System to more than 250 hospitals throughout the country, worth a potential $2,500,000 in revenue.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center or physician office. Additional information is available on the Company's Web site at www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:

    Solos Endoscopy, Inc.
    Investor Relations
    1-866-THE-APPL(E)